FDA cancels meeting to review Lilly’s Cymbalta
The agency said the meeting was canceled “to allow time for the FDA to review new information” about a proposed new use for
the drug.
Health Care & Insurance
Articles
Indiana nears 1M mark in swine-flu vaccinations
So far this year, 35 people have died in Indiana from swine flu.
Grass-roots groups prepare to fill gaps in health care reform
Legislation set to come out of Washington will not change the most fundamental problems of the health
care system, leaving it up to states, cities and companies to figure out what to do about it.
St. Francis sues OrthoIndy over new surgery center
Legal complaint alleges new $20 million facility in Greenwood breaches partnership deal struck in 2001.
Senate bill could hurt insurers in short term
The bill imposes hefty new taxes and coverage rules that will pinch insurers such as WellPoint Inc. by forcing them to cover
more sick people without gaining enough healthy, lower-cost customers, industry insiders say.
Corporations bet on insiders to bend reform
Indianapolis health care heavyweights are among those spending $635 million, employing 166 former aides to key congressional
leaders and committees in health reform process.
To keep sales force busy, Lilly takes on new drug
Eli Lilly and Co. has bought the rights to co-market a new cholesterol-fighting drug in the U.S., giving it a third heart drug for sales personnel
to push.
Senate OKs health care measure, but work remains
The Senate has passed President Barack Obama’s landmark health care overhaul in a climactic Christmas Eve vote, extending
medical insurance to 30 million Americans. But the Senate’s bill still must be merged with legislation passed by the House,
and there are significant differences.
Lilly scurries to get out from under Zyprexa cloud
Another year of rapid change at Eli Lilly and Co. did little to move the company out from under the cloud cast by its best-selling
drug, Zyprexa.
Health care industry braces for reform
Congress is on the cusp of transforming health insurance—if it can pass a health reform bill that was losing popularity
late in the year.
Building trades leaders flock to Wishard meetings
Hundreds of potential contractors turned out for informational meetings this week about construction work on a new Wishard Memorial Hospital.
Hoosier biz groups oppose Senate health bill
Group presidents tell Indiana senators that the reform bill would expand dysfunctions of current health care systems.
Conseco shoots for $222M in stock offering
The company plans to use at least $150 million to repay debt under its senior credit agreement. The remaining proceeds will
be used for general corporate purposes.
Senate rejects drug-importation proposal
The U.S. Senate voted down a plan Tuesday to allow Americans to import prescriptions from abroad, handing drug makers
such as Indianapolis-based Eli Lilly and Co. a victory.
Conseco offering new shares at $4.73 apiece
Carmel-based insurer hopes to raise $234 million through public offering.
Lilly wins approval for long-acting Zyprexa
Once-a-month injection of best-selling drug will have patents that could extend until 2018.
Dormir acquires two sleep companies
Carmel firm using $12 million in venture capital for buying spree is now nation’s second-largest operator of sleep centers.
Noble of Indiana to provide in-home services to disabled
The service will launch in February. Its goal is to serve 15 clients by June 30, 2010.
Health care reform would push state to hike Medicaid pay to docs
An actuarial report prepared by the local office of Milliman Inc., a Seattle-based consulting firm, projects
that the state of Indiana would have to hike its Medicaid payments by one-third in order to entice more
doctors into the program.
Plainfield’s MD Logistics sued by Bristol-Myers over lost insulin
Two semi-trailers of the medication were stolen in 2007 from a back lot at Daum Trucking, which isn’t named in the lawsuit.
Bristol-Myers charges MD Logistics with negligence in the $10.7 million suit.